An Open-label Study of ALPN-202 in Subjects With Advanced Malignancies
Clinical trial NCT04186637 · TERMINATED
Trial details
- NCT number
- NCT04186637
- Sponsor
- Alpine Immune Sciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-02
- Primary completion
- 2022-11-09
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.